Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
January 12, 2011 2:01 PM 2 min read

Emergency Care Now Top Priority - Analyst Blog

by Zacks Benzinga Contributor
Follow

Emergency Medical Services Corporation (EMS) is in an acquisition spree. Recently, the company's EmCare segment acquired Florida based North Pinellas Anesthesia Associates and Northwood Anesthesia Associates, an anesthesia provider. This acquisition will increase Emergency Medical's clinician strength by 40 persons apart from providing services to two hospitals and seven ambulatory surgical centers in that area. The company expects this deal to add $ 15 million in annual net revenue.

This is the second acquisition in the anesthesia space within a span of two months. Earlier, in December 2010, Emergency Medical had decided to acquire Milford Anesthesia Associates, an anesthesia provider based in Milford. With approximately 100 clinicians the anesthesia company provides its services to 9 hospitals and 18 ambulatory surgical centers. The transaction is expected to contribute $40 million of net revenue annually. Going by Emergency Medical's statement during the third quarter call, acquisitions in the area of anesthesia was quite planned out.

Emergency Medical's EmCare segment is a leading provider of outsourced emergency department staffing and related management services in the US based on the number of contracts with hospitals and affiliated physician groups. This segment commands an 8% share of the emergency department services market and 12% of the outsourced emergency department services market. During the third quarter of fiscal 2010, this segment generated revenues of $385.0 million, up 18% from the year-ago period.

Increased focus on cost containment, especially for the emergency departments in the hospital sector, coupled with complex regulatory/compliance requirement and a shortage of physicians trained to tackle emergency, should further push outsourcing trends in favor of well-established private providers of emergency department related services. Based on these factors, we believe EmCare should be able to consolidate its share in the $13 billion emergency department market.

We are currently Neutral on the stock.



EMERGENCY MEDIC (EMS
): Free Stock Analysis Report


Zacks Investment Research
Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Health CareHealth Care Services
Beat the Market With Our Free Pre-Market Newsletter
Enter your email to get Benzinga's ultimate morning update: The PreMarket Activity Newsletter
Comments
Loading...